Skip to main content
. 2020 Oct 22;11:593917. doi: 10.3389/fneur.2020.593917

Table 1.

Studies reporting auditory and/or vestibular symptoms with the use of cyclosporine.

Study Age n CsA treatment Follow-up Hearing loss eval. method Hearing loss Tinnitus Vestibular symptoms* Other drugs used
Indication Duration Dosage
Ibrahim et al. (26) 9.7 ± 3 yrs (5–16) 80 Idiopathic nephrotic syndrome 17 m (2–24) At least 12 m Pure tone audiometry 23.7% (19/80) Cyclophosphamide, methylprednisolone
Kasap-Demir et al. (27) 129.06 ± 63.25 m 16 Nephrotic syndrome (SDNS, FRNS, SRNS) 40.22 ± 35.14 (7–129) m Cumulative: 4,480.9 ± 3,652.86 (630–13,466) mg/kg 30.44 ± 19.88 m (1–53) Pure tone audiometry, TEOAE 0% 0% Steroids, rituximab, cyclophosphamide, levamisole, mycophenolate mofetil, angiotensin converting enzyme inhibitors
Gulleroglu et al. (28) 14.05 ± 4.11 yrs 27 Renal transplant 29.8 ± 22.5 m 21.3 ± 12.2 m Pure tone audiometry, questionnaire 63% (17/27) 4% (1/27) 0% Mycophenolate mofetil, prednisolone
Fortes et al. (29) 46.2 yrs 18 Liver transplant 636 days (65–939) Pure tone audiometry Prednisone, azathioprine, vancomycin, nystatin, sulfamethoxazole-trimethoprim
Rifai et al. (30) 51 ± 17 yrs 478 Orthotopic liver transplant 8 ± 5 yrs Questionnaire 15% (73/478) 11% (54/478) Tacrolimus, mycophenolate mofetil, prednisolone, sirolimus, azathioprine
Groothoff et al. (31) 29.3 yrs (20.7–41.7) 106 Renal transplant 11.3 yrs (0–29.9) Questionnaire 8% Prednisone, azathioprine, tacrolimus, antihypertensive (various)
Cole et al. (32) 46 yrs 1,097 Renal transplant 18 m - CsA: 257 ± 97 mg/day - CsA-ME: 248 ± 80 mg/day 18 m ? Overall: 4.7% (52/1,097) Prednisone, azathioprine

CsA, cyclosporine; CsA-ME, cyclosporine microemulsion; m, months; yrs, years; eval, evaluation; SDNS, steroid-dependent nephrotic syndrome; FRNS, frequently-relapsing nephrotic syndrome; SRNS, steroid-resistant nephrotic syndrome; TEOAE, transient evoked otoacoustic emissions.

*

dizziness, vertigo. Parenthesis represent range.